Wednesday, October 26, 2011

Longtime AIDS and Anti-Drugs Activist Hank Fiolle, Dies at 51

I emailed the author of the article: 
Mike, PLEASE get your facts right:
NO ONE was tested postiviely or otherwise for HIV in 1982: 1985
"The FDA (US) approves the first HIV antibody test. Blood products begin to be tested in the US and Japan. 2nd NO one dies from AIDS" complications of AIDS" 
AIDS is a only a definition... AIDS and HIV are two differnt things. 
"he never took AIDS med's and until Recently, was never ill from the virus" Again the virus, HIV and AIDS are two different things. Also i think you need to understand / learn what was the actual cause of death. 


By Mike Szymanski

Henry Lee “Hank” Fiolle, 51, died due to complications of AIDS at Cedars-Sinai Medical Center in Beverly Hills, Calif.
He spent the past two decades helping people with addition to alcohol and crystal meth through various 12-step and drug programs.
Fiolle attended William McKinley Elementary School, Bret Harte, Walter Reed Middle School and John Burroughs High School in Burbank.
Fiolle worked as an AIDS activist after he tested positive for HIV in 1982. He never took AIDS medications and until recently, was never ill from the virus.

Warning over HIV home test kits

from BBC NEWS:
Illegal home testing kits for HIV are giving people incorrect results, the Medicines and Healthcare products Regulatory Agency (MHRA) has warned.


It said there were issues with other tests for sexually transmitted diseases which were legal but might also be inaccurate.
The body is investigating a UK website which is selling the tests.

HIV: ADHERENCE IN 4 STEPS

Can you count all the misinformation in this video?
and talk about creating FEAR ...and offer a death sentence mentality.

Created by the Italian National Institute for Infectious Diseases
by Dr. Adriana Ammassari & Marzio Casa


Panel Endorses HPV Vaccine for Boys of 11

By  -NEW YORK TIMES


Here the CDC goes another way to give kids a Vaccine


Boys and young men should be vaccinated against human papillomavirus, or HPV, to protect against anal and throat cancers that can result from sexual activity, a federal advisory committee said Tuesday.


The recommendation by the panel, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, is likely to transform the use of the HPV vaccine, since most private insurers pay for vaccines once the committee recommends them for routine use. The HPV vaccine is unusually expensive. Its three doses cost pediatricians more than $300, and pediatricians often charge patients hundreds more.

Monday, October 24, 2011

HIV/AIDS Neutralizing Antibody Points To New Path For Vaccine

Posted by Claire Shefchik - thirdage.com



An antibody that gains hold of the HIV/AIDS virus has revealed a new potential target for developing a vaccine for the virus, a Scripps Research Institute study showed.

HIV tests are better than 99% accurate...

by Gos Blank 

...BUT there's a catch:  If you test positive, "accuracy" is a meaningless term.  No competent and responsible medical professional should EVER use the term "accuracy" to describe a positive HIV test result.  (And yet, 99% of HIV testing professionals do this regularly, suggesting that they are neither competent nor responsible.)

Here's why:

Sunday, October 23, 2011

Taiwan University Hospital: Five Recipients of HIV-Positive Organs Test HIV-Negative

From U.S. Centers for Disease Control and Prevention

On Thursday, Taiwan University Hospital reported that five transplant patients who mistakenly received organs from a deceased HIV-positive donor continue to test HIV-negative. Medical staff started the organ recipients on HIV prophylaxis a day after discovering the transplant error, which occurred on Aug. 24. Two patients remain hospitalized, while three have been discharged, said Chang Shan-Chwen, TUH's vice superintendent.

CHIMPS INFECTED WITH HIV FREED – The Catch 22 in HIV Infection


by Beldeu Singh

It was big news in the mainstream media. A group of Chimpanzees had been locked up in metal cages for 30 years. They were kept by a firm that bought them that had the aim to find a vaccine to combat AIDS. The chimps were thought to be natural subjects because chimps share 99 per cent of the genome of man. Several years ago, the giant American pharmaceutical company Baxter took over the Austrian laboratory, and immediately announced it had no intention of continuing the testing program. “They suffered terrible cruelties in the years that followed, including being injected with the HIV virus. Hooked up to machines and pumped full of chemicals, they were truly prisoners of utter despair. With no stimulation, no nurturing love and no hope, many were driven to the brink of madness and beyond.”

What made the news and turned it into headlines? “Their ordeal finally ended on Tuesday when the 38 surviving chimps were released into a £3million sanctuary in Austria, allowing them to feel the nurturing contact of their fellow chimps after years of being separated by bars and bullet-proof glass.” Certainly a celebration but they missed the real news created by the laboratory to find a vaccine fir AIDS by injecting the so called HIV into the chimps but the chimps did not develop full-blown AIDS and they failed to find the vaccine. The failure to find a vaccine ought, rightly, to be the correct and the more exciting headline.
The news report said that “some chimpanzees were infected with the HIV virus. Of course, they became HIV positive. But none of them, not here in Austria or anywhere else in the world, developed full-blown Aids. Therefore, the program was useless. It achieved absolutely nothing.”
To get to the bottom of the matter embedded in this news, one has to grasp a number of issues as follows:-
  1. Why Dr. Gallo uses supernatants and not isolates?
  2. How do you do a clinical study comprising AIDS patients and HIV infection when the test kits carry a disclaimer stating that the test kits cannot be used to diagnose and treat AIDS and to use a confirmatory test?
  3. Why there are a large number of false positives with tests using these test kits, including people recovering from malaria and flu?
  4. Why do the HIV test kits test for p24, the significance of which is not known?
  5. What is the real role of gp120 in the infection process and in immune-suppression?
  6. Why give toxic drugs as medication to AIDs patients that suppress the immune system or are “toxic by inhalation” and “can cause the same symptoms as AIDS”?
  7. What is the treatment for drug-induced AIDS? More of the toxic medication?
  8. If AIDS is caused by a virus, why is there a latency period?

Monday, October 17, 2011

HIV patients' life expectancy rises - London Derry Sentine.co.uk


“More Britons than ever have HIV – but their life expectancy after diagnosis has never been higher,” The Independent has today reported. The newspaper said new research has shown that the life expectancy of UK HIV patients had improved by 16 years in the past decade.
The news is based on a study that looked at data on over 17,000 adults with HIV who were treated with antiretroviral drugs, which have now become a standard treatment for slowing the progress of the virus. By analysing data on deaths among this population, researchers estimated that antiretroviral users aged 20 in 1996 would be expected to live to an average age of 50 but that by 2008, this group were expected to live to an average age of almost 66 years.

AZT: This Drug stopped Bone Marrow from Producing Blood and Killed the liver.

Sunday, October 16, 2011

Discrepancy between government reported AIDS deaths in South Africa

Health Alert Communications: 


A confidential commercial report on South Africa by a medical consultant. Although only the first 6 of 76 pages are publicly available it reveals the massive discrepancy between government reported AIDS deaths (6,235 in 1997 to 15,097 in 2008) versus UN estimates (360,000 in 1997 to 310,000 in 2009).
INTERVIEW WITH DR. JAMES CHIN, FORMER CHIEF OF GLOBAL HIV SURVEILLANCE FOR THE WORLD HEALTH ORGANIZATION

Saturday, October 15, 2011

Scientists working to develop HIV and AIDS vaccines in Georgia - Rome News-tribune

“That’s a market worth $1.5 billion to $4 billion annually,” Dodd said.
Umm about the money or finding a Vaccines?


David Dodd, chariman of GeoVax,
(Doug Walker, RN-T.com)
Georgia is a developing hotbed for biological science. “There is a lot of biological life science research going on in Georgia that most Georgians know nothing about. It’s all about improving life,” said GeoVax Labs chairman David Dodd at the Greater Rome Chamber of Commerce Spectrum of Technology IV on Friday.

Dodd said that his one of his companies, VaxyGen Manufacturing, had just signed on to become the newest member of the Georgia Research Alliance.

The company is working with several academic partners in Georgia to cut down on the lead-time of taking AIDS and HIV vaccines from concept through clinical trials to the marketplace. “We are leading the world in the development of vaccines for HIV/AIDS,” Dodd said.

Dodd said that the estimated cost that an individual will pay during his or her lifetime after contracting HIV is close to half a million dollars. Nationally, the cost of treating the virus in the United States is an estimated $27.5 billion each year.

He said that if a preventative vaccine that was just 50 percent effective could be given to 30 percent of the population, that it could reduce the number of new infections by close to 17 million over the next 15 years.

“That’s a market worth $1.5 billion to $4 billion annually,” Dodd said. He said the good news related to HIV/AIDS is that the number of new infections each year has dropped from its high of close to 130,000 annually in the late 1980s to approximately 55,000-58,000 a year today.

His company is the second phase of development for a couple of vaccines and told the audience that of some 80 clinical programs for preventative vaccines, only five have been completed successfully and GeoVax has two of the five. He is hoping to get actual clinical trial started for the drugs sometime in 2012.

He told the large group at The Forum in Rome that the biological life sciences work being done in Georgia is second to none.

“We’re translating science into technology and adding value to lives,” Dodd said. “It presents tremendous opportunities to continue to build value and build jobs”


Read more: RN-T.com - Scientists working to develop HIV and AIDS vaccines in Georgia 

20 pct of Latinos with HIV don't know it - UPI -Health News


Create FEAR:
ATLANTA, Oct. 15 (UPI) -- Approximately one in 50 Latinos in the United States can expect to be diagnosed with HIV in his or her lifetime, federal health officials said.
Among Latino men, the Centers for Disease Control and Prevention estimated 81 percent of infections occur among gay and bisexual men, with the largest number of new infections among gay and bisexual men age 30 and under compared to other age groups.
HIV infection rates among Latino men are almost three times higher than among white men, while HIV infection rates among Latinas are four times higher than among white women.
CDC recommends all adolescents and adults get tested for HIV, regardless of whether they think they are at risk.
"Getting an HIV test is one of the simplest and most effective things we all can do to take control of our health," Dr. Kevin A. Fenton, director of the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention at the Centers for Disease Control and Prevention, said in a statement. "Simply put, knowing your status -- and getting treated if you are infected -- can save your life. Today in the United States, about one in five Latinos infected with HIV doesn't know it. That's because more than half of Latinos have never been tested."


Read more: http://www.upi.com/Health_News/2011/10/15/20-pct-of-Latinos-with-HIV-dont-know-it/UPI-28401318653187/#ixzz1arkAW4zR

Monday, October 10, 2011

Looking for long term survivors in the struggle against the HIV virus and AIDS for the end of a New Film's gallery


LONG TERM SURVIVORS GALLERY 
We have come almost to the end of the making of "Positively False - birth of a heresy", a 90 minute feature length documentary. I attach a brief synopsis of the film.

The film will be premiered in the US in Washington DC on 2nd December at the Rethinking AIDS Conference, RA2011.

We would like to include at the end of the film a gallery of long term survivors in the struggle against the tyranny of the virus/AIDS hypothesis.

We would be grateful if you would agree to be included in this gallery by sending us your name, a photograph of yourselves and a few lines about your situation.

  • When did you test antibody positive?
  • Did you try to avoid taking antivirals? Did you succeed?
  • How is your health now?
Positively False - Birth of a Heresy
 traces the challenge over the
past 25 years to the scientific orthodoxy which maintains that HIV is the
cause of AIDS.

HIV-positive man guilty of passing virus during sex


  • A jury decided James Rick told partner of his status, but did not take preventive action.

A Hennepin County jury believed that Daniel James Rick told his partner he was HIV positive before they had sex following a night out in May 2009.
They still found the 30-year-old Minneapolis man guilty of a felony in an unusual case that could broadly affect the prosecution of similar HIV transmission cases.
It took the jury about two hours last Friday to convict Rick of attempted first-degree assault after a weeklong trial.
Attorney Landon Ascheman vowed to appeal the verdict against his client, saying that prosecutors used a vague interpretation of a 16-year-old state law to convict Rick, who faces prison time and who is charged with two similar offenses for allegedly infecting two other men without sharing his HIV status.
"Because he didn't use any protection, it didn't matter if he told or not," Ascheman said the jury determined. "Reading the statute exactly as it is, they were told they essentially had to convict him."
According to statute 609.2241, a person commits a crime when transferring a communicable disease through "sexual penetration with another person without having first informed the other person" of their positive status, or by the "transfer of blood, sperm, organs or tissue, except as deemed necessary for medical research or if disclosed on donor screening forms."
The jury found Rick not guilty under the first section of the statute, but convicted him on the second, an interpretation Ascheman criticized as overly broad and intended to apply to medical procedures rather than sexual intercourse.
Hennepin County Attorney Mike Freeman, who called Rick's case "extraordinary," denied Ascheman's assertions.
"You look at what the Legislature is trying to do, they set it forth in clear language, and does what he did fit in with the language of the statute?" Freeman said. "He knowingly transferred these fluids through unprotected sex knowing he had HIV, and knowing HIV can be deadly, that is not overly broad."
Freeman said communicable diseases are defined as those causing serious illness, disability or death. The law does not apply to curable or treatable sexually transmitted diseases such as syphilis or gonorrhea. He disagreed with the jury's finding that Rick disclosed his status to the victim, but said he was grateful that they still found Rick guilty. He said the case, believed to be the first of its kind using the statute, does not mean two partners automatically would be charged for having unprotected sex when one is HIV-positive. Doing so "would be abusing our discretion," he said.
The victim declined to comment.
According to charges, Rick and the victim, who worked at the Saloon Bar, recognized Rick there in May 2009 from an online chat and struck up a conversation, according to the criminal complaint.
After work, the man went to Rick's home, where they had sex without using condoms, the complaint said. According to prosecutors, Rick did not say he was HIV-positive, but Ascheman told jurors that his client had disclosed he was HIV positive before the men had sex. The man later tested HIV-positive. According to the complaint, he had tested negative before having sex with Rick. According to the charges, Rick tested positive for HIV in January 2006 and received counseling about safe-sex practices.
Faces similar charges
Rick faces three more counts of attempted first-degree assault and third-degree criminal sexual conduct in earlier cases that caused his victim in last week's trial to come forward.
He was charged in February 2010 with raping a drunken man after a night out in downtown Minneapolis, transferring the virus to him. The publicity from that case led two men to come forward the next month who accused Rick of not disclosing having the virus when he had sex with them after the partners met him over a website. One of the men contracted the virus, while the other did not.
A trial date will be set for those cases when Rick is sentenced Nov. 28. Rick also pleaded guilty to felony third-degree criminal sexual conduct for having sex with a 15-year-old in Sherburne County. He received two months' jail time and probation.
Abby Simons • 612-673-4921

Thursday, October 6, 2011

AIDS Rethinking presented in Mainstream Conferences


AIDS Rethinking was again disseminated to mainstream researchers, this time at the65th Annual Congress of the Italian Society for Anatomy and Histology  in Padua, 27-29 September 2011.
An extensive poster presentation (authors: Ruggiero, Pacini, Punzi, Morucci, Gulisano, Köhnlein, Bauer) discussed “The Clinical Significance of Immune-System Laboratory Tests”. The poster makes the following salient points:
→   Scientists accept conclusions of experts in fields outside their own specialties. The resulting mainstream “consensus” can remain unchanged for a long time even after the experts have modified or discarded their earlier conclusions.
→    That is so with HIV/AIDS, where evidence has accumulated that the original hypothesis was wrong:
♦    Kaposi’s sarcoma is not caused by HIV.
♦    Many clinical AIDS cases were found to be HIV-negative
(and renamed — entirely ad  hoc — “idiopathic CD4-T-cell lymphopenia”).
♦    Anti-retroviral drugs often cause clinical deterioration instead of
helping patients recover (“immune restoration syndrome”).
Patients on Highly Active Anti-Retroviral Therapy (HAART)
experience more adverse non-AIDS events than AIDS events.
♦    “HIV” tests are anything but specific; false-positives arise from a host of conditions
that are not necessarily health-threatening.
♦    CD4 counts are not a good biomarker of clinical condition, nor a criterion of illness,
still less a reason for instituting HAART.

Friday, September 30, 2011

CDC now calling U.S. households and demanding child immunization records as part of vaccine surveillance and tracking programy Mike Adams, the Health Rang

by Mike Adams, the Health Ranger
(NaturalNews) The U.S. Centers for Disease Control, which has been comprehensively exposed as a vaccine propaganda organization promoting the interests of drug companies, is now engaged in a household surveillance program that involves calling U.S. households and intimidating parents into producing child immunization records. As part of what it deems aNational Immunization Survey(NIS), the CDC is sending letters to U.S. households, alerting them that they will be called by "NORC at the University of Chicago" and that households should "have your child's immunization records handy when answering our questions." (See copies of the letter, below.)

Wednesday, September 28, 2011

Hide-And-Seek: Altered HIV Can't Evade Immune System - ScienceDaily

A model of HIV showing the
organization of membrane associated
cholesterol (in yellow).
(Credit: Image courtesy of
Johns Hopkins Medical
Institutions/Jenny Wang)
 
ScienceDaily (Sep. 28, 2011) — Researchers at Johns Hopkins have modified HIV in a way
that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

"Something about the HIV virus turns down the immune response, rather than triggering it, making it a tough target for vaccine development," says David Graham, Ph.D., assistant professor of molecular and comparative pathobiology and medicine. "We now seem to have a way to sidestep this barrier," he adds.
Typically, when the body's immune system cells encounter a virus, they send out an alarm by releasing chemicals called interferons to alert the rest of the body to the presence of a viral infection. When the immune cells encounter HIV, however, they release too many interferons, become overwhelmed and shut down the subsequent virus-fighting response.
The researchers had learned from other studies that when human immune cells (white blood cells) are depleted of cholesterol, HIV can no longer infect them. It turns out the coat that surrounds and protects the HIV viral genome also is rich in cholesterol, leading the Johns Hopkins team to test whether viruses lacking cholesterol could still infect cells at all.

Monday, September 26, 2011

THE MYTH THAT VACCINATION EQUALS IMMUNIZATION


By Gary Null and Nancy Ashley
Currently, the American public through our government agencies, the CDC, the FDA the US Public Health Service, the National Institute of Allergy and Infectious Diseases is being told that only by vaccinating all children and infants, all adults and seniors can we confer complete protective immunity from major diseases, whether H1N1, the seasonal flu, chicken pox, measles, hepatitis, etc. to any given individual. Their arguments have never been put to the test. It is virtually impossible to have open, independent, objective scientific and public health discourse. You either accept without challenge that vaccines provide permanent lifetime immunity, or you are immediately relegated as a quack. However, a careful analysis and review of the scientific literature shows that no vaccine or combination of vaccines can be proven to confer complete immunity and be safe.

Saturday, September 24, 2011

Expert: 'Functional Cure for HIV/AIDS Within a Decade'--and Seattle is Playing a Vital Role in Developing It

By Jonathan Walczak - blogs.seattleweekly.com
Research into developing a widely available, functional cure for HIV/AIDS is moving at breakneck speed, prompted by the case of a former Seattle man who became the first person ever curedof the virus, and carried out, in part, by Seattle-area researchers.
"I would be incredibly disappointed if we didn't have a functional cure for AIDS in the next decade," says Jeffrey Laurence, a Cornell University researcher and a consultant for The American Foundation for AIDS Research.
A dozen doctors from around the nation, including three from Seattle, met last week in Philadelphia to discuss their research.

Much of their work focuses on CCR5, essentially a doorway HIV uses to enter cells.